Abeona Therapeutics Inc.

NASDAQ:ABEO

Biotechnology

Healthcare
$2.73 +1.06%

+$0.06 today

Market cap
$156.01M
Beta
1.35
P/E (TTM)
4.9
EPS (TTM)
$1.17
52W Low $4.00High $7.54

Volume 1.71M

Average 1.12M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$76.33M

FY 2025 · Annual

Investing Cash Flow

$105.03M

FY 2025 · Annual

Financing Cash Flow

$26.04M

FY 2025 · Annual

-75.0% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(84.94M)(39.7M)(54.19M)(63.73M)71.18M
Depreciation & Amortization4.46M4.58M3.2M2.91M3.56M
Deferred Income Tax00000
Stock-Based Compensation8.92M3.05M4.77M6.63M10.78M
Change in Working Capital(18.26M)(5.89M)(1.79M)(4.38M)(5.39M)
Accounts Receivables(3M)2.81M(2.04M)792K(5.06M)
Inventory0000(5.49M)
Accounts Payables(15.59M)(9.11M)2.04M(3.49M)6.54M
Other Working Capital324K404K(3.83M)(1.68M)(1.37M)
Other Non-Cash Items24.15M(5.52M)11M2.57M(156.46M)
Operating Cash Flow(65.67M)(43.48M)(37.01M)(56.02M)(76.33M)
Capital Expenditures(4.15M)(130K)(331K)(2.45M)(7.98M)
Acquisitions (Net)00000
Purchases of Investments(20.16M)(78.21M)(51.64M)(157.01M)(206.63M)
Sales of Investments90.38M52.64M51.97M120.2M167.27M
Other Investing Activities01.73M204K18K152.37M
Investing Cash Flow66.06M(23.96M)208K(39.24M)105.03M
Debt Repayment00020M0
Common Stock Issued24.03M46.96M37.39M85.63M26.08M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities831K(5K)(332K)(1.49M)(37K)
Financing Cash Flow24.86M43.17M37.06M104.14M26.04M
Effect of Forex Changes00000
Net Change in Cash25.26M(24.27M)256K8.88M54.74M
Free Cash Flow(69.82M)(43.61M)(37.34M)(58.46M)(84.3M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$71.2M
+ D&A$3.6M
+ Stock-Based Comp$10.8M
+ Deferred Tax$0
- Working Capital-$5.4M
- Other Non-Cash-$156.5M
= Operating Cash Flow-$76.3M
- Capex-$8.0M
= Free Cash Flow-$84.3M

Analysis

FY2025 free cash flow is -$84.3M. FCF conversion is -118.4% of net income. Operating cash flow was -$76.3M, with capex of -$8.0M. The largest bridge item is Other Non-Cash at -$156.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 12, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 9, 2026

Does ABEO generate free cash flow?

Abeona Therapeutics Inc. (ABEO) generated -$84.30M of free cash flow in fiscal 2025.

How much operating cash flow does ABEO produce?

Operating cash flow was -$76.33M, before capital expenditures of $7.97M.